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We have previously demonstrated that rat uterine epithelial cells (UEC) produce CCL20/macrophage
inflammatory protein 3 alpha (MIP3) and tumor necrosis factor alpha (TNF-) in response to live and
heat-killed Escherichia coli and to the pathogen-associated molecular patterns (PAMP) lipopolysaccharide
(LPS) and Pam3Cys. To determine whether estradiol (E2) modulates PAMP-induced CCL20/MIP3 and
TNF- secretion, primary cultures of rat UEC were incubated with E2 for 24 h and then treated with LPS or
Pam3Cys or not treated for an additional 12 h. E2 inhibited the constitutive secretion of TNF- and CCL20/
MIP3 into culture media. Interestingly, E2 pretreatment enhanced CCL20/MIP3 secretion due to LPS and
Pam3Cys administration. In contrast, and at the same time, E2 lowered the TNF- response to both PAMP. To
determine whether estrogen receptors (ER) mediated the effects of E2, epithelial cells were incubated with E2
and/or ICI 182,780, a known ER antagonist. ICI 182,780 had no effect on E2 inhibition of constitutive TNF-
and CCL20/MIP3 secretion. In contrast, ICI 182,780 reversed the stimulatory effect of E2 on LPS- and/or
Pam3Cys-induced CCL20/MIP3 secretion as well as partially reversed the inhibitory effect of E2 on TNF-
production by epithelial cells. Overall, these results indicate that E2 regulates the production of TNF- and
CCL20/MIP3 by UEC in the absence as well as presence of PAMP. Since CCL20/MIP3 has antimicrobial
activity and is chemotactic for immune cells, these studies suggest that regulation of CCL20/MIP3 and TNF-
by E2 and PAMP may have profound effects on innate and adaptive immune responses to microbial challenge
in the female reproductive tract.
Effective immune protection to microbial challenge in mam-
mals is based on responses of both the innate and adaptive
immune systems. Immune responses in the female reproduc-
tive tract pose a special problem. There must be effective
immune protection against microbial infection but tolerance to
the presence of allogeneic sperm and a fetal placental unit.
Estrogen regulation of immune responses, both systemically
and in the female reproductive tract, is an essential part of
normal physiology (57, 58). It has been observed that, com-
pared to men, the higher levels of estrogen in women lead to
enhanced antibody and cell-mediated immune responses fol-
lowing infection or vaccination (4). Epithelial cells in the
uterus and at other mucosal surfaces release cytokines that
affect the migration and maturation of stromal immune cells
(9, 11, 28, 42, 45). Estradiol (E2) has been shown to play an
important role in modulating the release of cytokines by uter-
ine tissues (24, 27, 29, 44, 47). However, little is known about
the effects of E2 on uterine epithelial cell responses to poten-
tial pathogens. This emphasizes the need to more fully define
the interactions between estradiol and epithelial cells that, in
addition to being a physical barrier, provide protection by
signaling to immune cells distant from the site(s) of infection.
Studies over the last decade demonstrating the rapid and
continuous movement of vaginal contents into the lumen of the
uterus and the Fallopian tubes (31–34) along with an increased
appreciation for the relationship of perturbations of vaginal
flora to maternal/fetal morbidity and mortality (5, 20, 55) have
focused our attention on innate immune protection and the
response of uterine epithelial cells (UEC) to bacteria and bacte-
rial cell wall components (8, 9, 41, 49). Epithelial cells that form
a physical barrier that lines the uterus, when cultured in vitro in
cell culture inserts, reestablish a polarized monolayer similar to
that seen in histological sections of uterine tissue.
Responses to estrogens are cell type and tissue specific in
that E2 acting within the reproductive tract can have opposite
effects. For example, in response to estradiol, antigen presen-
tation by uterine epithelial cells increases but antigen presen-
tation in the underlying stroma is inhibited (59). What is now
widely accepted is that estrogen responses are mediated
though several receptors. On the one hand, E2 exerts its effects
though intracellular nuclear receptors that elicit genomic re-
sponses (56). The estrogen receptor (ER) consists of at least
two isoforms (ER and ER) which have overlapping but
discrete functions (18). Estradiol may also act through mem-
brane-associated receptors that utilize nongenomic pathways
(38, 43). In other studies, E2 acts through soluble factors pro-
duced by underlying stromal cells that stimulate epithelial cell
proliferation and tight junction formation (7, 10, 17). Indirect
effects such as the influence of stromal cells on epithelial cell
growth are known to require the presence of the ER in stromal
cells (7).
* Corresponding author. Mailing address: Department of Physiol-
ogy, Dartmouth Medical School, Borwell Building, 1 Medical Center
Drive, Lebanon, NH 03756. Phone: (603) 650-7733. Fax: (603) 650-
6130. E-mail: Mardi.Crane@Dartmouth.edu.
4231
Studies presented previously by our laboratory demonstrate
that CCL20/macrophage inflammatory protein 3 alpha
(MIP3) and tumor necrosis factor alpha (TNF-) are pro-
duced by uterine epithelial cells in response to exposure to
Escherichia coli as well as to the specific toll-like receptor
(TLR) 2 and TLR4 agonists (Pam3Cys and lipopolysaccharide
[LPS]) (8, 9). While CCL20/MIP3 plays a role in the devel-
opment and maintenance of normal immune cell populations
in mucosal tissues (6, 26), it has also been found in association
with autoimmune lesions, including histiocytosis and autoim-
mune encephalomyelitis (1, 3). E2 and progesterone regulate
uterine epithelial cell expression of TNF- mRNA and protein
through the estrous cycle (11). In some studies E2 is inhibitory,
while in others it appears to stimulate TNF- production by
uterine epithelial cells (23, 47). While no direct effects of E2 on
CCL20/MIP3 have been reported, some studies indicate that
TNF- up-regulates CCL20/MIP3 gene expression (14, 19,
37, 52, 53).
The overall goal of the studies presented in this paper was to
test the hypothesis that E2 regulates the stimulation by patho-
gen-associated molecular patterns (PAMP) of CCL20/MIP3
and TNF- secretion by polarized rat UEC in culture. Our
objectives were the following: (i) to identify cell culture con-
ditions that would optimize the detection of responsiveness of
epithelial cells to the presence of E2; (ii) to determine if E2
influences the constitutive release of CCL20/MIP3 and
TNF- by uterine cells; and (iii) to examine the role of E2 in
regulating PAMP-stimulated release of CCL20/MIP3 and
TNF- in UEC.
MATERIALS AND METHODS
Animals. Specific-pathogen-free Lewis rats weighing from 125 to 175 g
(Charles River Breeding Laboratories, Kingston, NY) were used in all studies.
Animals were maintained with alternating 12-h dark/light cycles and given free
access to food and water. All procedures involving these rats were conducted
following protocols approved by the Dartmouth College Institutional Animal
Care and Use Committee.
Preparation of epithelial cell cultures. All cell cultures were established by
pooling the uteri of five or more animals at various stages of the estrous cycle (7).
Briefly, rat uteri were removed, rinsed in sterile ice-cold Hank’s balanced salt
solution (Gibco, Grand Island, NY), weighed, and then transferred to a pancre-
atin (Gibco), trypsin (Sigma, St. Louis, MO), DNase (Worthington, Lakewood,
NJ) digest (400 U of DNase/ml of pancreatin, 46,500 U of trypsin/ml of pancre-
atin, 19.5 ml of pancreatin/gram of uterine tissue). Uteri were minced and
incubated for 1 h at 4°C on a rotating platform at 60 rpm. The tissues were then
moved to room temperature for an additional 60 min of incubation. Tissues were
vortexed vigorously for 10 to 15 s prior to being poured through a sterile 250-m
nylon mesh screen to remove tissue fragments from suspension of cells prior to
recovering epithelial cell sheets. Rinses of the uterine tissues with culture media
(described below) produced a cell suspension. Epithelial cell sheets were recov-
ered by pouring the resulting suspension onto a 20-m mesh capture screen and
then collected and suspended in medium and plated on growth factor-reduced
Matrigel-coated 10-mm by 0.4-m polycarbonate membrane inserts (Nalgene
Nunc International) at a density of one rat uterus per three to four cell culture
insert wells. In experiments using NUNC cell culture inserts, cells were plated in
500 l of medium in the apical compartment, and 500 l of medium was placed
in the basolateral compartment.
Uterine epithelial cells were incubated at 37°C in 5% CO2 and allowed to
develop into polarized confluent monolayer cultures. Treatments of polarized
cultures described for individual experiments took place between days 4 and 7
from the day that cultures were established. The presence of a confluent mono-
layer of epithelial cells that has formed tight junctions (16) was determined by
measuring transepithelial resistance (TER) on an EVOM Voltohmmeter (World
Precision Instruments). Measurements were taken using a sterile chopstick type
probe preconditioned in medium prior to each session. This device conducts an
electrical current across the epithelial cell culture being measured, and resistance
to the current is displayed on the EVOM Voltohmmeter. A Matrigel-coated
control well containing medium was measured at each session to determine
background resistance.
Culture media. In preliminary studies (data not included), a variety of media
as well as cell culture inserts were tested for the ability to support rat uterine
epithelial cell growth in culture. To optimize conditions for rat uterine epithelial
cell culture, we used F12K medium (American Type Culture Collection, Rock-
ville, MD) plus 10% defined fetal bovine serum (F12K-DS) supplemented with
100 g/ml streptomycin and 100 U/ml penicillin to initiate cell cultures. When
average TER exceeded 1,000 /well (generally on day 4), media were replaced
with F12K medium plus 10% charcoal-dextran-stripped fetal bovine serum
(F12K-SS), also supplemented with 100 g/ml streptomycin and 100 U/ml pen-
icillin. After 24 h of incubation with F12K-SS medium and continued monitoring
of TER, cultures were exposed to F12K-SS medium containing E2 or ICI
182,780. In experiments with LPS or Pam3Cys and E2, cell cultures were exposed
to the hormone in F12K-SS medium for 12 to 24 h prior to treatment with
PAMP.
Treatment of epithelial cells with PAMP. PAMP, including Pam3Cys, a syn-
thetic analog of bacterial lipopeptides (L2000 EMC Microcollections, Tuebin-
gen, Germany), and repurified (ultrapure) lipopolysaccharides (R595, Salmo-
nella minnesota; List Biological Laboratories, Campbell, CA), were reconstituted
in sterile endotoxin-free irrigation water under sterile conditions. Cell cultures
were treated with PAMP in the apical compartment at a dose of 1 g/ml in all
experiments. Medium was harvested at the end of the experimental period(s) for
analysis. PAMP were tested by Limulus assay (Limulus Amebocyte Lysate QCL-
1000; Biowhittaker) for the presence of endotoxin. Pam3Cys (1 g/ml) contained
0.018 endotoxin U/ml.
Hormone treatment. To prepare hormone for cell incubation, E2 (Calbio-
chem, La Jolla, CA) was dissolved in 100% ethanol, evaporated to dryness, and
then resuspended in F12K-SS medium. The estrogen receptor antagonist ICI
182,780 (Tocris, Ellisville, MO) was prepared in the same manner. To control for
any residue from the ethanol, an equivalent amount of ethanol was evaporated
in another container and used to prepare control medium used in the experi-
ments. After epithelial cell cultures had grown to confluence as determined by
TER, F12K-DS was replaced with F12K-SS medium as described above. UEC
cultures were incubated in F12K-SS medium for 24 h prior to transfer to new
plates containing medium and treated with E2 and/or ICI 182,780 in F12K-SS at
concentrations indicated in figure legends and Results.
Measurement of CCL20/MIP3 and TNF-. CCL20/MIP3 and TNF- were
measured using an enzyme-linked immunosorbent assay (ELISA) kit for rat
MIP3 or rat TNF- (DuoSet ELISA Development System; R&D Systems,
Minneapolis, MN). Directions and materials supplied with these commercial kits
were followed exactly for CCL20/MIP3 assays. However, in order to increase
the sensitivity of the TNF- ELISA, the standard protocol was modified by
increasing the amount of capture antibody and detection antibody to 120% of
normal concentration. Also, the concentration of streptavidin-horseradish per-
oxidase was increased to 125% of that called for in the standard protocol. These
modifications permitted consistent measurement of TNF- of 5 pg/ml.
Statistics. Error bars in all figures refer to variations between wells (four to six
wells/treatment). Data were compared by one-way analysis of variance
(ANOVA) followed by a Tukey multiple comparison posttest. Student’s t test
was used only as indicted in figure legends. Differences with P values of 0.05
were considered significant.
RESULTS
Effect of fetal bovine serum and E2 on epithelial cell TER.
Since mouse uterine epithelial cells respond to E2 in culture
with lower TER (17) and because TER measures the electrical
integrity of polarized epithelial cells (16), a study was under-
taken to determine the effect of E2 on rat UEC incubated
initially in F12K-DS medium and then switched to F12K me-
dium containing stripped serum (F12K-SS). This switch was
made because defined fetal bovine serum contains estrogens,
while the levels in stripped serum are below the level of de-
tection (Hyclone Technical Support, personal communica-
tion). Following culture in F12K-SS for 48 h, some wells were
treated with F12K-SS with E2 (10
7 M). As seen in Fig. 1,
treatment with E2 had no effect on epithelial TER measured at
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24 and 48 h (days 7 and 8) after treatment. Moreover, this
study, which is representative of five experiments, indicated
that transition from F12K-DS to F12K-SS had no effect on
TER.
Effect of E2 on constitutive and PAMP-induced release of
CCL20/MIP3 and TNF- by uterine epithelial cells. To de-
termine the effect of E2 on the constitutive release of CCL20/
MIP3 and TNF-, UEC were grown in F12K-DS for 3 to 4
days prior to transfer into F12K-SS. Following 24 h in F12K-
SS, media were changed and cells were incubated in the pres-
ence or absence of E2 (10
8 M) for an additional 24 h. Cells
were incubated in fresh medium (with E2 or control) for an
additional 12 h, after which basolateral medium was collected
for ELISA analysis. Others have shown that the dissociation
constants (Kds) for ER and ER in the rodent uterus are 0.1
and 0.4 nM, respectively (30). To ensure saturation of recep-
tors, which occurs between 109 and 108 M, as well as to
account for the loss of free estradiol in culture owing to ad-
herence to plastic and association with proteins in stripped
serum, estradiol was added to the incubation media at concen-
trations ranging from 108 to 107 M. As seen in Fig. 2, E2
added to the incubation medium at 108 M as well as 107 M
(not shown) significantly inhibited the constitutive release of
CCL20/MIP3 and TNF- by uterine epithelial cells.
In contrast, with cultures pretreated with E2 (10
8 M) for
24 h prior to addition of either LPS or Pam3Cys for 12 h, E2
doubled secretion of CCL20/MIP3 into the basolateral com-
partment compared to either PAMP alone (Fig. 3A). Unex-
pectedly, E2 had the opposite effect on the TNF- response to
LPS and Pam3Cys, inhibiting TNF- secretion (Fig. 3B). These
findings indicate that in response to LPS and Pam3Cys, estra-
diol exerts opposite effects on CCL20/MIP3 and TNF- re-
lease.
Response of uterine epithelial cells in culture to treatment
with the estrogen receptor antagonist ICI 182,780. To deter-
mine whether the effects of E2 on uterine epithelial cell secre-
tion of CCL20/MIP3 and TNF- were mediated through the
estrogen receptor, cell cultures were grown as described above
for 24 h in F12K-SS medium prior to a 24-h period of treat-
ment with medium containing E2 (10
8 M), ICI 182,780 (106
M), or both, after which cells were treated apically with LPS or
Pam3Cys. Following a 12-h incubation, basolateral media were
analyzed for the presence of CCL20/MIP3 or TNF-. ICI
182,780, a known antagonist of E2 binding to ER, hardly re-
versed the inhibitory effect of E2 on CCL20/MIP3 constitu-
tive release (Fig. 4A). In contrast, when ICI 182,780 was added
along with E2 to PAMP-treated cells, the stimulatory effect of
E2 alone on CCL20/MIP3 release was reversed (Fig. 4B and
C). A similar pattern of ICI 182,780 activity was observed when
TNF- was analyzed (Fig. 5). ICI 182,780 had little effect on E2
inhibition of constitutive release of TNF- (Fig. 5A) but al-
most completely reversed the inhibitory effect of E2 on TNF-
release in response to LPS (Fig. 5B). When cells were treated
with Pam3Cys, ICI 182,780 also did not reverse the inhibitory
effect of E2 on Pam3Cys-stimulated release of TNF- (Fig.
5C). Overall, these studies indicate that ICI 182,780 reversal of
estradiol effects may or may not occur, depending on the
PAMP involved and the conditions under which CCL20/
MIP3 and TNF- are secreted (constitutively or stimulated).
DISCUSSION
The research presented here demonstrates that the secretion
of CCL20/MIP3 and TNF- by rat uterine epithelial cells is
influenced by estradiol. We show that E2 significantly inhibits
the constitutive release of both CCL20/MIP3 and TNF-. In
contrast, when both E2 and PAMP are present, E2 increases
FIG. 1. Development of TER of uterine epithelial cells switched to
F12K-SS and treated with E2. On day 4 of culture, UEC cultures were
switched to F12K media with stripped serum. One group was then
treated with E2 (10
7 M). Values shown are mean TER  standard
error (SE) per group of four to five wells each. This figure is repre-
sentative of methods used and results of five experiments.
FIG. 2. Effect of E2 on constitutive basolateral release of cytokines.
For uterine epithelial cells cultured as described in Materials and
Methods, following a change to fresh medium and a 12-h incubation in
fresh medium or medium with E2 (10
8 M), basolateral media were
harvested and analyzed by ELISA. Values shown are means of cyto-
kine levels  SE of five wells per group. Results for each cytokine are
representative of three or more separate experiments. *, significantly
(P  0.05) different from cytokine measured in control cultures; **,
significantly (P  0.01) different from cytokine measured in control
cultures.
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CCL20/MIP3 production beyond that seen with PAMP stim-
ulation alone. These studies indicate that E2 has an inhibitory
effect on the basolateral release of TNF- in the presence as
well as the absence of PAMP. Moreover, this work demon-
strates that ICI 182,780, which has little or no effect on revers-
ing the inhibitory action of E2 treatment on the constitutive
release of TNF- or CCL20/MIP3, reverses the stimulatory
effect of E2 on CCL20/MIP3 release in response to LPS and
Pam3Cys as well as partially reverses the inhibitory effect of E2
in the presence of LPS.
Production of CCL20/MIP3 at other mucosal surfaces, in-
cluding the lungs and gastrointestinal tract, is enhanced by
pathogenic challenge (36, 51). Previously, we demonstrated
that polarized uterine epithelial cells in culture produce
CCL20/MIP3 in response to live and heat-killed E. coli as
well as selected PAMP (8, 9). To the best of our knowledge,
our finding that estradiol exerts a stimulatory effect on CCL20/
MIP3 is the first demonstration that this chemokine is under
hormonal control. Moreover, these studies demonstrate a
unique role of estradiol, in that constitutive release of CCL20/
MIP3 is inhibited by estradiol, whereas the release of CCL20/
MIP3 in response to PAMP is stimulated by estradiol. That
release of CCL20/MIP3 in response to PAMP is ER medi-
ated is suggested by our finding that when added along with
estradiol, ICI 182,780, a receptor antagonist of estradiol, re-
verses the stimulatory effects of estradiol on CCL20/MIP3
secretion. In contrast, when estradiol and ICI 182,780 were
added to cell cultures releasing CCL20/MIP3 under consti-
tutive release conditions, the effect of estradiol was not re-
versed.
The complexities of regulation observed in these studies
suggest that estradiol acts though different pathways to differ-
entially control CCL20/MIP3 and TNF- production. This
may explain the apparent contradiction of our findings with
those of others who have shown that TNF- plays an important
FIG. 3. Effect of E2 on PAMP-stimulated release of (A) CCL20/
MIP3 and (B) TNF-. Rat uterine epithelial cell cultures grown as
described in Materials and Methods were treated with ultrapure LPS
(1 g/ml) or Pam3Cys (1 g/ml) with or without E2 (10
8 M). Baso-
lateral media were harvested after a 12-h incubation, and CCL20/
MIP3 and TNF- levels were determined by ELISA. Values shown
are means of cytokine levels  SE for five wells per group. Results are
representative of four experiments for LPS treatment and two exper-
iments for Pam3Cys. **, significantly (P  0.01) different from cytokine
measured in cultures treated with PAMP alone.
FIG. 4. Effect of ICI 182,780 and E2 treatment on CCL20/MIP3.
Rat uterine epithelial cell cultures as described in Materials and Meth-
ods were treated with E2 (10
8 M), ICI 182,780 (106 M), or both,
prepared in F12K stripped medium. Twelve hours after hormone
treatment, all cell cultures received fresh hormone-treated medium,
and some were also treated with ultrapure LPS (1 g/ml) (B) or
Pam3Cys (1 g/ml) (C). Basolateral media were harvested after a 12-h
incubation, and the level of CCL20/MIP3 was determined by ELISA.
Values shown are means of cytokine levels  SE of four wells per
group. Results are representative of four experiments for LPS treat-
ment and two experiments for Pam3Cys. Asterisks indicate significant
differences (*, P  0.05; **, P  0.01) from cytokine measured in
(A) medium, (B) medium plus LPS, or (C) medium plus Pam3Cys
control cultures. ##, significantly (P  0.01) different from (B) LPS
plus E2 or (C) Pam3Cys plus E2 cytokine measured in E2-treated
cultures.
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role in stimulating CCL20/MIP3 production (14, 19, 37, 52,
53). For example, estradiol is able to bind to different isoforms
of the same receptor and may either increase or decrease
mRNA expression, the net result being either enhanced or
suppressed cytokine secretion. Alternatively, since cytokines
such as TNF- are known to exist as procytokines, estradiol
may act on matrix metalloproteinase to either enhance or
suppress processing and/or release from epithelial membranes
(15, 21).
Our findings that the constitutive release of TNF- and
CCL20/MIP3 is inhibited by E2 suggest that in the absence of
potential pathogens, E2, produced during the reproductive cy-
cle, acts in the uterus to suppress these two proinflammatory
molecules. Unexpected was our finding that under conditions
of PAMP stimulation, E2 increased CCL20/MIP3 release
while continuing to inhibit TNF- secretion. Estradiol levels in
blood vary with the stage of the reproductive cycle, with high-
est levels measured just prior to ovulation and mating (50).
Our finding that CCL20/MIP3 is differentially regulated by
estradiol suggests that CCL20/MIP3 production in the uterus
may vary with the stage of the cycle. If transferable to in vivo
situations, CCL20/MIP3 production may be inhibited in the
uterus by estradiol if mating does not occur, while under con-
ditions of mating and the presence of bacteria, estradiol may
stimulate the release of CCL20/MIP3, thus affording protec-
tion against infection. The observed influx of leukocytes that
occurs in the uterus following mating (46, 54) may in part be
attributable to putative increases in CCL20/MIP3. Since an
additional dimension of CCL20/MIP3 immune protection is
its ability to act as a microbicide (22), elevated levels of
CCL20/MIP3 stimulated by estradiol at mating might protect
by limiting bacterial growth until such time that recruitment of
immune cells can occur.
Estradiol influences on CCL20/MIP3 and TNF- are com-
plex and may be associated with genomic and/or nongenomic
effects of E2. Estradiol is known to influence genes when the
liganded ER binds to an Sp1 promoter site (12, 48). In other
studies, it has been demonstrated that the promoter region of
the CCL20/MIP3 gene contains an Sp1 promoter sequence
(35). This offers an explanation for a mechanism whereby es-
tradiol could influence the transcription of CCL20/MIP3. In
contrast to the stimulatory role of estrogen on the transcription
of CCL20/MIP3, the TNF- promoter contains an estrogen
inhibitory element (2). Nongenomic effects of E2 in the endo-
metrium have also been reported. For example, treatment of
endometrial cells in culture with E2 results in Ca
2 influx
within 10 min, and treatment of ovariectomized rats with E2
results in changes in the morphology of uterine epithelial cells
within 1 min (13, 39, 40). Some of the nongenomic effects of E2
are reported not to be antagonized by the ER antagonist ICI
182,780 (13). For example, in a study of neurite growth, the
effects of E2 could be inhibited by an inhibitor of cyclic AMP/
PKA and Ca2 signaling pathways but not by ICI 182,780. This
and other studies have shown that ICI 182,780 antagonism of
the effects of E2 is complex. Further studies are needed to
define the mechanism(s) whereby E2 exerts its effects on
TNF- and CCL20/MIP3 production by uterine epithelial
cells.
In conclusion, estradiol influences the production of CCL20/
MIP3 and TNF- by uterine epithelial cells both constitu-
tively and in response to PAMP. Estradiol regulation of the
release of CCL20/MIP3 and TNF- suggests that the mucosal
immune cell response to the presence of bacteria in the repro-
ductive tract is precisely regulated and coordinated with the
reproductive cycle to optimize the potential for successful
mammalian reproduction.
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FIG. 5. Influence of ICI 182,780 and E2 treatment on TNF-. Rat
uterine epithelial cell cultures as described in Materials and Methods
were treated with E2 (10
8 M), ICI 182,780 (106 M), or both, pre-
pared in F12K stripped medium. Twelve hours after hormone treat-
ment, all cell cultures received fresh hormone-treated medium, and
some were also treated with ultrapure LPS (1 g/ml) (B) or Pam3Cys
(1 g/ml) (C). Basolateral media were harvested after a 12-h incuba-
tion, and TNF- level was determined by ELISA. Values shown are
means of cytokine levels  SE of four wells per group. Results are
representative of four experiments for LPS treatment and two exper-
iments for Pam3Cys. **, significantly (P  0.01) different from cytokine
measured in (A) medium, (B) medium plus LPS, or (C) medium plus
Pam3Cys control cultures by ANOVA. 		, significantly (P  0.05)
different from Pam3Cys control by t test but not by ANOVA.
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